Medtronic | MDT - Current Liabilities



Medtronic reported $12.88B in Current Liabilities for its fiscal quarter ending in April of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
AtriCure USD 68.84M 7.62M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Danaher USD 6.79B 147M Jun/2025
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Globus Medical USD 424.66M 39.96M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Masimo USD 592.1M 45.6M Jun/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merit Medical Systems USD 225.57M 28.75M Jun/2025
Philips EUR 7.2B 445M Jun/2025
Smith & Nephew USD 1.54B 10M Jun/2025
Stryker USD 7.29B 641M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
Terumo JPY 271.9B 30.93B Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025